285 related articles for article (PubMed ID: 30392339)
1. [Performance of combined liquid based cytology and HPV nucleic acid test for detecting cervical precancer among women attending screening].
Jiang MY; Feng RM; Wang L; Li TY; Zhang AA; Cui JF; Pan QJ; Zhang X; Liu ML; Gao F; Chen W; Qiao YL
Zhonghua Zhong Liu Za Zhi; 2018 Oct; 40(10):750-756. PubMed ID: 30392339
[No Abstract] [Full Text] [Related]
2. Methylation estimates the risk of precancer in HPV-infected women with discrepant results between cytology and HPV16/18 genotyping.
Hernández-López R; Lorincz AT; Torres-Ibarra L; Reuter C; Scibior-Bentkowska D; Warman R; Nedjai B; Mendiola-Pastrana I; León-Maldonado L; Rivera-Paredez B; Ramírez-Palacios P; Lazcano-Ponce E; Cuzick J; Salmerón J;
Clin Epigenetics; 2019 Oct; 11(1):140. PubMed ID: 31606044
[TBL] [Abstract][Full Text] [Related]
3. Combined use of cytology, p16 immunostaining and genotyping for triage of women positive for high-risk human papillomavirus at primary screening.
Cuzick J; Adcock R; Carozzi F; Gillio-Tos A; De Marco L; Del Mistro A; Frayle H; Girlando S; Sani C; Confortini M; Zorzi M; Giorgi-Rossi P; Rizzolo R; Ronco G;
Int J Cancer; 2020 Oct; 147(7):1864-1873. PubMed ID: 32170961
[TBL] [Abstract][Full Text] [Related]
4. DNA methylation testing with S5 for triage of high-risk HPV positive women.
Adcock R; Nedjai B; Lorincz AT; Scibior-Bentkowska D; Banwait R; Torrez-Martinez N; Robertson M; Cuzick J; Wheeler CM;
Int J Cancer; 2022 Oct; 151(7):993-1004. PubMed ID: 35477862
[TBL] [Abstract][Full Text] [Related]
5. Performance of HPV16/18 in Triage of Cytological Atypical Squamous Cells of Undetermined Significance.
Cao X; Liu S; Jia M; Chen H; Zhao D; Dong B; Guo Z; Ren L; Zhang S; Sun X
Anal Cell Pathol (Amst); 2019; 2019():4324710. PubMed ID: 31934532
[TBL] [Abstract][Full Text] [Related]
6. p16/ki67 and E6/E7 mRNA Accuracy and Prognostic Value in Triaging HPV DNA-Positive Women.
Giorgi Rossi P; Carozzi F; Ronco G; Allia E; Bisanzi S; Gillio-Tos A; De Marco L; Rizzolo R; Gustinucci D; Del Mistro A; Frayle H; Confortini M; Iossa A; Cesarini E; Bulletti S; Passamonti B; Gori S; Toniolo L; Barca A; Bonvicini L; Mancuso P; Venturelli F; Benevolo M;
J Natl Cancer Inst; 2021 Mar; 113(3):292-300. PubMed ID: 32745170
[TBL] [Abstract][Full Text] [Related]
7. Optimal Management Strategies for Primary HPV Testing for Cervical Screening: Cost-Effectiveness Evaluation for the National Cervical Screening Program in Australia.
Simms KT; Hall M; Smith MA; Lew JB; Hughes S; Yuill S; Hammond I; Saville M; Canfell K
PLoS One; 2017; 12(1):e0163509. PubMed ID: 28095411
[TBL] [Abstract][Full Text] [Related]
8. Performance of OncoE6
Ndizeye Z; Menon S; Van Geertruyden JP; Sauvaget C; Jacquemyn Y; Bogers JP; Benoy I; Vanden Broeck D
BMJ Open; 2019 Sep; 9(9):e029088. PubMed ID: 31494606
[TBL] [Abstract][Full Text] [Related]
9. 16/18 genotyping in triage of persistent human papillomavirus infections with negative cytology in the English cervical screening pilot.
Rebolj M; Brentnall AR; Mathews C; Denton K; Holbrook M; Levine T; Sargent A; Smith J; Tidy J; Tyler X; Kitchener H;
Br J Cancer; 2019 Sep; 121(6):455-463. PubMed ID: 31409912
[TBL] [Abstract][Full Text] [Related]
10. The influence of type-specific human papillomavirus infections on the detection of cervical precancer and cancer: A population-based study of opportunistic cervical screening in the United States.
Wheeler CM; Hunt WC; Cuzick J; Langsfeld E; Robertson M; Castle PE;
Int J Cancer; 2014 Aug; 135(3):624-34. PubMed ID: 24226935
[TBL] [Abstract][Full Text] [Related]
11. Human papilloma virus genotyping for the cross-sectional and longitudinal probability of developing cervical intraepithelial neoplasia grade 2 or more.
Del Mistro A; Adcock R; Carozzi F; Gillio-Tos A; De Marco L; Girlando S; Rizzolo R; Frayle H; Trevisan M; Sani C; Burroni E; Giorgi Rossi P; Cuzick J; Ronco G;
Int J Cancer; 2018 Jul; 143(2):333-342. PubMed ID: 29453769
[TBL] [Abstract][Full Text] [Related]
12. Performance of Different Follow-Up Strategies and Genotype-Based Recurrence Risk After Treatment of Cervical High-Grade Squamous Intraepithelial Lesion.
Graça J; Preti M; Pollano B; Vieira-Baptista P
J Low Genit Tract Dis; 2024 Apr; 28(2):131-136. PubMed ID: 38465957
[TBL] [Abstract][Full Text] [Related]
13. Detection of cervical high-grade squamous intraepithelial lesions and assessing diagnostic performance of colposcopy among women with oncogenic HPV.
Li X; Xiang F; Zhao Y; Li Q; Gu Q; Zhang X; Chen Z; Zhang M; Wang J; Liu R; Kang X; Wu R
BMC Womens Health; 2023 Aug; 23(1):411. PubMed ID: 37542333
[TBL] [Abstract][Full Text] [Related]
14. Triage strategies in cervical cancer detection in Mexico: methods of the FRIDA Study.
Torres-Ibarra L; Lazcano-Ponce E; Franco EL; Cuzick J; Hernández-Ávila M; Lorincz A; Rivera B; Ramírez P; Mendiola-Pastrana I; Rudolph SE; León-Maldonado L; Hernández R; Barrios E; Gravitt P; Moscicki AB; Schmeler KM; Flores YN; Méndez-Hernández P; Salmerón J;
Salud Publica Mex; 2016 Apr; 58(2):197-210. PubMed ID: 27557378
[TBL] [Abstract][Full Text] [Related]
15. The Role of Human Papillomavirus Genotyping in Cervical Cancer Screening: A Large-Scale Evaluation of the cobas HPV Test.
Schiffman M; Boyle S; Raine-Bennett T; Katki HA; Gage JC; Wentzensen N; Kornegay JR; Apple R; Aldrich C; Erlich HA; Tam T; Befano B; Burk RD; Castle PE
Cancer Epidemiol Biomarkers Prev; 2015 Sep; 24(9):1304-10. PubMed ID: 26088703
[TBL] [Abstract][Full Text] [Related]
16. Clinical human papillomavirus detection forecasts cervical cancer risk in women over 18 years of follow-up.
Castle PE; Glass AG; Rush BB; Scott DR; Wentzensen N; Gage JC; Buckland J; Rydzak G; Lorincz AT; Wacholder S
J Clin Oncol; 2012 Sep; 30(25):3044-50. PubMed ID: 22851570
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of a methylation classifier for predicting pre-cancer lesion among women with abnormal results between HPV16/18 and cytology.
Gu YY; Zhou GN; Wang Q; Ding JX; Hua KQ
Clin Epigenetics; 2020 Apr; 12(1):57. PubMed ID: 32317020
[TBL] [Abstract][Full Text] [Related]
18. Extended Human Papillomavirus Genotyping to Predict Progression to High-Grade Cervical Precancer: A Prospective Cohort Study in the Southeastern United States.
Bukowski A; Hoyo C; Hudgens MG; Brewster WR; Valea F; Bentley RC; Vidal AC; Maguire RL; Schmitt JW; Murphy SK; North KE; Smith JS
Cancer Epidemiol Biomarkers Prev; 2022 Aug; 31(8):1564-1571. PubMed ID: 35654413
[TBL] [Abstract][Full Text] [Related]
19. Cost-effectiveness of using human papillomavirus 16/18 genotype triage in cervical cancer screening.
Vijayaraghavan A; Efrusy MB; Goodman KA; Santas CC; Huh WK
Gynecol Oncol; 2010 Nov; 119(2):237-42. PubMed ID: 20713299
[TBL] [Abstract][Full Text] [Related]
20. Is phased implementation of HPV testing and triage with dual staining the way to transform organized cytology screening?
Sláma J; Dvořák V; Trnková M; Skřivánek A; Hrabcová K; Ovesná P; Nováčková M
Eur J Cancer Prev; 2024 Mar; 33(2):168-176. PubMed ID: 37751376
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
